Latest News and Press Releases
Want to stay updated on the latest news?
-
23. oktober 2024 Pressemeddelelse BioPorto præsenterer den FDA-godkendte ProNephro AKI (NGAL) test på ASN Kidney Week 2024 Conference KØBENHAVN, Danmark og BOSTON, MA, USA, 23. oktober, 2024 (GLOBE...
-
October 23, 2024 News Release BioPorto Presenting FDA-cleared ProNephro AKI (NGAL) at ASN Kidney Week 2024 Conference COPENHAGEN, Denmark and BOSTON, MA, USA, October 23, 2024,...
-
22. oktober, 2024 Pressemeddelelse BioPorto er stolte af at have ni af de ti bedste amerikanske børnehospitaler som kunder hos NGAL KØBENHAVN, Danmark og BOSTON, MA, USA, 22. oktober, 2024 (GLOBE...
-
October 22, 2024 News Release BioPorto is proud to have Nine of the top-ten best US Children’s hospitals as customers of NGAL COPENHAGEN, DENMARK and BOSTON, MA, USA, October 22,...
-
21. oktober 2024Pressemeddelelse BioPorto A/S annoncerer ændringer til den amerikanske kommercielle organisation KØBENHAVN, DANMARK og BOSTON, MA, USA, 21. oktober, 2024 (GLOBE NEWSWIRE) –-...
-
October 21, 2024 News release BioPorto A/S Announces Changes to the US Commercial Organization COPENHAGEN, DENMARK and BOSTON, MA, USA, October 21, 2024, (GLOBE NEWSWIRE) -- BioPorto...
-
October 10, 2024 News Release BioPorto Announces Appointment of National Principal Investigator and Selection of CRO for Upcoming USA ICU Adult AKI Clinical Study ...
-
15. august 2024 Pressemeddelelse Første 6 måneder af 2024: Fortsat stærk vækst i salget af NGAL-tests i USA og fokuseret eksekvering af alle elementer i BioPortos strategi København,...
-
August 15, 2024Announcement no. 18 BioPorto Announces Interim Results and Business Update for the Second Quarter and Six Months of Fiscal 2024 Continued strong growth in US sales...
-
August 7, 2024News Release BioPorto A/S to Host Second Quarter 2024 Earnings Webcast & Investor Meeting COPENHAGEN, DENMARK and BOSTON, MA, USA, August 7, 2024 (GLOBE...